{"id":"https://genegraph.clinicalgenome.org/r/5ed6e2d0-a9a2-4dd7-be4d-c3e6e0b63e62v1.0","type":"EvidenceStrengthAssertion","dc:description":"There is abundant evidence published associating the RECQL4 gene with Rothmund-Thomson Syndrome since the gene-disease relationship was first proposed by Kitao et al. (1999). Multiple case level studies have been performed with RTS patients that have variants in the RECQL4 gene. WRN and BLM, another two RecQ DNA helicases, are associated with Werner and Bloom syndromes. All three are disorders of chromosomal instability and manifest growth retardation, premature aging, and predisposition to malignancies. RT-PCR analysis of RECQL4 cDNA from patient's cells showed diffuse splicing defects. Defective repair of H2O2-induced DNA lesions was reported in primary RTS patient's cell line, AG05013. Multiple RECQL4 deficient mouse models have been established to show consistent phenotypes with RTS patients, including growth retardation, skin and several other tissue abnormalities, birth defects of the skeletal system and increased cancer susceptibility. All of these types of evidence are consistent with a definitive relationship between the RECQL4 gene and Rothmund-Thomson Syndrome (RTS).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5ed6e2d0-a9a2-4dd7-be4d-c3e6e0b63e62","GCISnapshot":"https://genegraph.clinicalgenome.org/r/dbf00cfa-ac36-4eb0-94c4-69b05014e0f6","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/dbf00cfa-ac36-4eb0-94c4-69b05014e0f6_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/dbf00cfa-ac36-4eb0-94c4-69b05014e0f6_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2018-10-11T17:00:00.000Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dbf00cfa-ac36-4eb0-94c4-69b05014e0f6_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dbf00cfa-ac36-4eb0-94c4-69b05014e0f6_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/88dc0bab-1c70-46b9-bfa0-1f4c00a72b44","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/75f06a63-60a3-4785-81a8-165ff33f0453","type":"Finding","dc:description":"Mutant mice exhibited a distinctive skin abnormality, birth defects of the skeletal system, genomic instability and increased cancer susceptibility in a sensitized genetic background. Cells from Recql4-mutant mice had high frequencies of premature centromere separation and aneuploidy.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15703196","rdfs:label":"A mouse model of type II Rothmund–Thomson syndrome","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5dc2f170-0249-4cf1-abe8-4bf128e89df4","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/690c1d57-a87a-4458-a022-6be633eb286a","type":"Finding","dc:description":"Helicase activity-inhibited mice (lacking exon 13 of Recql4) were viable, but exhibited severe growth retardation, abnormalities in several tissues, and defective proliferation of embryonic fibroblasts. Abnormalities in the Recql4-deficient mice were similar to those in RTS patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12915449","rdfs:label":"Growth retardation/skin abnormalities Recql4-deficient mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/dbf00cfa-ac36-4eb0-94c4-69b05014e0f6_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b2031679-fecd-4210-a22a-f87ee1315088","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0e921b76-a26c-4ccf-a2e9-f8aa2d19447b","type":"FunctionalAlteration","dc:description":"Primary Rothmund-Thomson syndrome (RTS) cell line, AG05013, accumulated more H2O2-induced DNA strand breaks than control cells, suggesting that RECQL4 stimulate repair of H2O2-induced DNA damage. RTS primary fibroblasts also accumulated more XRCC1 foci than control cells in response to endogenous or induced oxidative stress, and had a high basal level of endogenous formamidopyrimidines.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19567405","rdfs:label":"Defective repair of H2O2-induced DNA lesions in RTS cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/dbf00cfa-ac36-4eb0-94c4-69b05014e0f6_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/579f3249-dbd7-4207-81d7-50449a93d410","type":"EvidenceLine","dc:description":"Give 0.25 points each for WRN and BLM.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dbbef614-f841-4d43-8a84-20a9d1eb0bc2","type":"Finding","dc:description":"Mammals have five genes that encode different RecQ DNA helicases. Humans have RECQL4, RECQL, BLM, WRN and RECQL5. Loss-of-function mutations in WRN, BLM and RECQL4 cause the autosomal recessive disorders Bloom (BS), Werner (WS) and Rothmund–Thomson (RTS) syndromes, respectively. All three are disorders of chromosomal instability and manifest growth retardation, premature aging, and predisposition to malignancies.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10678659","rdfs:label":"WRN and BLM are associated with Werner and Bloom syndromes","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4f885517-6236-481a-b3d6-b49434858b31","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb72c280-1a4d-4705-9a47-c3ba864a686c","type":"Finding","dc:description":"RT-PCR analysis of RECQL4 cDNA encompassing the entire helicase domain showed diffuse splicing defects indicating that the loss of a single 30-splice signal motif disregulates the correct splice-site selection and affects the overall RNA processing.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12838562","rdfs:label":"RT-PCR analysis showed diffuse splicing defects","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/dbf00cfa-ac36-4eb0-94c4-69b05014e0f6_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f084c4c-6746-4ff7-baa7-4367167ef3b4_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A 2269C-T transition resulting in a gln757-to-ter substitution (Q757X). It is a two star variant in ClinVar.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fbea7001-0b8d-461b-a0a3-f85e7c72bd14","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12734318","rdfs:label":"FCP-125","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":9,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0004322","obo:HP_0001029","obo:HP_0002652","obo:HP_0002669"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/6f084c4c-6746-4ff7-baa7-4367167ef3b4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12734318","allele":{"id":"https://genegraph.clinicalgenome.org/r/49a44470-3ea1-483d-b5ab-401c8a32a00c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004260.3(RECQL4):c.2269C>T (p.Gln757Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6063"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/56f3d9ed-5c36-433a-800d-3c6c9d9f99a2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygosity for 2 mutations of the RECQL4 gene: a 2-bp deletion (designated mut-3) and a G-to-T transversion at the junction of intron 12 and exon 13 that destroyed the splicing acceptor sequence (mut-4). Both mutations were associated with a translational frameshift. Exon 13 was deleted in the case of the mut-4 allele.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ab8dfdd8-acca-4cf4-a28c-c1e9705de83d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10319867","rdfs:label":"European descent","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0004334","obo:HP_0000924","obo:HP_0007713"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/56f3d9ed-5c36-433a-800d-3c6c9d9f99a2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10319867","allele":[{"id":"https://genegraph.clinicalgenome.org/r/6029db60-4bf3-414b-94c9-0968ad9ee32b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004260.3(RECQL4):c.2059-1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6065"}},{"id":"https://genegraph.clinicalgenome.org/r/3fffd7f2-03f8-4720-9957-f71bfaa58852","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004260.3(RECQL4):c.2492_2493delAT (p.His831Argfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6064"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9389f111-a84e-4f73-9e69-5bada5ead057_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygosity for Q757X and a 1-bp deletion (g.2886delT) in the RECQL4 gene.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a609364-b4fe-45a0-b571-2d604db6042d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12734318","rdfs:label":"FCP-129","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":4,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0004322","obo:HP_0001029","obo:HP_0002652","obo:HP_0002669"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/9389f111-a84e-4f73-9e69-5bada5ead057_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12734318","allele":[{"id":"https://genegraph.clinicalgenome.org/r/96c0247f-c91e-446b-9385-d78338e75e79","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004260.3(RECQL4):c.1573delT (p.Cys525Alafs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6066"}},{"id":"https://genegraph.clinicalgenome.org/r/49a44470-3ea1-483d-b5ab-401c8a32a00c"}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/dbf00cfa-ac36-4eb0-94c4-69b05014e0f6_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fb02e570-91a9-4760-838e-2ff6b614d34e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10678659","rdfs:label":"Two brothers","estimatedLodScore":0.85,"family":{"id":"https://genegraph.clinicalgenome.org/r/fb02e570-91a9-4760-838e-2ff6b614d34e","type":"Family","rdfs:label":"Two brothers","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/0b52d86c-5b85-4ab9-a63b-fd5d739721ca","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10678659","rdfs:label":"II.1 and II.2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":21,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0002669","obo:HP_0002293","obo:HP_0004334"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f774099f-ff35-4d02-8d01-f1b8966d08b7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10678659","allele":[{"id":"https://genegraph.clinicalgenome.org/r/d1be22ac-7c11-46e4-bf88-fa9f92dc6c10","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004260.3(RECQL4):c.1391-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6067"}},{"id":"https://genegraph.clinicalgenome.org/r/96c0247f-c91e-446b-9385-d78338e75e79"}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":2,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0004334","obo:HP_0002293","obo:HP_0002669"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0b52d86c-5b85-4ab9-a63b-fd5d739721ca"}},{"id":"https://genegraph.clinicalgenome.org/r/4697eb5d-87a2-4cb1-8668-1df81875df81_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10319867","rdfs:label":"Mexican ancestry","estimatedLodScore":1.35,"family":{"id":"https://genegraph.clinicalgenome.org/r/4697eb5d-87a2-4cb1-8668-1df81875df81","type":"Family","rdfs:label":"Mexican ancestry","ethnicity":{"id":"cg:HispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/61c770ac-e20f-49dc-aa2a-d9be54ad6d70","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10319867","rdfs:label":"II-3 and II-6","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","ethnicity":{"id":"cg:HispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000924","obo:HP_0007713","obo:HP_0004334"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/da295251-a125-4dc1-9ed1-3366dacd349a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10319867","allele":[{"id":"https://genegraph.clinicalgenome.org/r/49a44470-3ea1-483d-b5ab-401c8a32a00c"},{"id":"https://genegraph.clinicalgenome.org/r/f636efb7-fb5b-4ff1-beee-e69fc7c60724","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004260.3(RECQL4):c.1650_1656delGGCCTGC (p.Ala551Tyrfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6062"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":6,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0007713","obo:HP_0004334","obo:HP_0000924"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/61c770ac-e20f-49dc-aa2a-d9be54ad6d70"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/3a8b785a-45a2-4d99-a6ba-1c24687b34e5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygosity for a 6-bp deletion (1919delTCACAG) in exon 12 of the RECQL4 gene and a splice site mutation (1704+1G-A) in intron 10.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/383ea5ab-5d4d-4fba-9c80-4470d0d6f61b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20503338","rdfs:label":"a patient","ageType":"AgeAtReport","ageUnit":"Years","ageValue":21,"detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0030669","obo:HP_0012191","obo:HP_0006721","obo:HP_0012193","obo:HP_0002669","obo:HP_0001029"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3a8b785a-45a2-4d99-a6ba-1c24687b34e5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20503338","allele":[{"id":"https://genegraph.clinicalgenome.org/r/0abcfc7a-726c-41fb-9025-5827bf99d146","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004260.3(RECQL4):c.1704+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6077"}},{"id":"https://genegraph.clinicalgenome.org/r/90cc903b-1cad-42af-8ae1-7b24cb3d02f1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004260.3(RECQL4):c.1919_1924delTCACAG (p.Leu640_Ala642delinsPro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6076"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f774099f-ff35-4d02-8d01-f1b8966d08b7_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Compound heterozygous for mutations in the RECQL4 gene: a 1-bp deletion in exon 9 (c.1573delT, referred to as 'mut -5), resulting in a frameshift and premature termination codon, and a G-to-A transition at the 3-prime splice site in the intron-exon boundary of exon 8, resulting presumably in anomalous mRNA with a 93-bp deletion.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b52d86c-5b85-4ab9-a63b-fd5d739721ca"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/da295251-a125-4dc1-9ed1-3366dacd349a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"One mutation, referred to as mut-1, was a deletion of 7 bases (GGCCTGC; nucleotides 1650-1656) resulting in an early termination codon (TGA) 14 bases downstream. The second mutation, mut-2: a 2269C-T transition resulting in a gln757-to-ter substitution (Q757X). It is a two star variant in ClinVar.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/61c770ac-e20f-49dc-aa2a-d9be54ad6d70"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":140,"specifiedBy":"GeneValidityCriteria6","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/Vc9554AeQRo","type":"GeneValidityProposition","disease":"obo:MONDO_0010002","gene":"hgnc:9949","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_dbf00cfa-ac36-4eb0-94c4-69b05014e0f6-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}